PoliticalRepoPoliticalRepo

United States · Bill · S

S. 2212 (115th)

National Biomedical Research Act

referredUnited States· United States Congress· EN

Introduced

7 December 2017

Last action

7 December 2017 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Elizabeth Warren, Bernie Sanders, Sen. Casey, Robert P., Jr. [D-PA], Sen. Franken, Al [D-MN], Michael Bennet, Sheldon Whitehouse, Tammy Baldwin, Christopher Murphy, Timothy Kaine, Maggie Hassan, Rep. Cardin, Benjamin L. [D-MD-3], Chris Van Hollen, Edward Markey, Sen. Hirono, Mazie K. [D-HI], Sen. Booker, Cory A. [D-NJ], Sen. Harris, Kamala D. [D-CA]

Subjects

Healthcare

Source updated

11 August 2025

Healthcare

Summary

National Biomedical Research Act This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative research.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 7 December 2017

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

  2. 7 December 2017

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.